학술논문

Divergent clonal selection dominates medulloblastoma at recurrence
Document Type
article
Author
Morrissy, A SoranaGarzia, LiviaShih, David JHZuyderduyn, ScottHuang, XiSkowron, PatrykRemke, MarcCavalli, Florence MGRamaswamy, VijayLindsay, Patricia EJelveh, SalomehDonovan, Laura KWang, XinLuu, BettyZayne, KoryLi, YisuMayoh, ChelseaThiessen, NinaMercier, EloiMungall, Karen LMa, YusanneTse, KaneZeng, ThomasShumansky, KareyRoth, Andrew JLShah, SohrabFarooq, HamzaKijima, NoriyukiHolgado, Borja LLee, John JYMatan-Lithwick, StuartLiu, JessicaMack, Stephen CManno, AlexMichealraj, KANor, CarolinaPeacock, JohnQin, LeiReimand, JuriRolider, AdiThompson, Yuan YWu, XiaochongPugh, TrevorAlly, AdrianBilenky, MikhailButterfield, Yaron SNCarlsen, RebeccaCheng, YoungChuah, EricCorbett, Richard DDhalla, NoreenHe, AnLee, DarleneLi, Haiyan ILong, WilliamMayo, MichaelPlettner, PatrickQian, Jenny QSchein, Jacqueline ETam, AngelaWong, TinaBirol, InancZhao, YongjunFaria, Claudia CPimentel, JoséNunes, SofiaShalaby, TarekGrotzer, MichaelPollack, Ian FHamilton, Ronald LLi, Xiao-NanBendel, Anne EFults, Daniel WWalter, Andrew WKumabe, ToshihiroTominaga, TeijiCollins, V PeterCho, Yoon-JaeHoffman, CaitlinLyden, DavidWisoff, Jeffrey HGarvin, James HStearns, Duncan SMassimi, LucaSchüller, UlrichSterba, JaroslavZitterbart, KarelPuget, StephanieAyrault, OlivierDunn, Sandra ETirapelli, Daniela PCCarlotti, Carlos GWheeler, HelenHallahan, Andrew RIngram, WendyMacDonald, Tobey JOlson, Jeffrey JVan Meir, Erwin GLee, Ji-YeounWang, Kyu-Chang
Source
Nature. 529(7586)
Subject
Pediatric
Biotechnology
Genetics
Brain Disorders
Human Genome
Brain Cancer
Rare Diseases
Cancer
Animals
Cerebellar Neoplasms
Clone Cells
Craniospinal Irradiation
DNA Mutational Analysis
Disease Models
Animal
Drosophila melanogaster
Female
Genome
Human
Humans
Male
Medulloblastoma
Mice
Molecular Targeted Therapy
Neoplasm Recurrence
Local
Radiotherapy
Image-Guided
Selection
Genetic
Signal Transduction
Xenograft Model Antitumor Assays
General Science & Technology
Language
Abstract
The development of targeted anti-cancer therapies through the study of cancer genomes is intended to increase survival rates and decrease treatment-related toxicity. We treated a transposon-driven, functional genomic mouse model of medulloblastoma with 'humanized' in vivo therapy (microneurosurgical tumour resection followed by multi-fractionated, image-guided radiotherapy). Genetic events in recurrent murine medulloblastoma exhibit a very poor overlap with those in matched murine diagnostic samples (